A. M. Horrevorts
- Epidemiology top 10%
- Molecular Medicine top 2%
- Infectious Diseases top 10%
- Pharmacology top 10%
- Parasitology top 5%
- Co-authors
- Marc MichelJohan W. MoutonJacques F. MeisLenie DijkshoornIngela TjernbergK. F. KerrebijnPaul MulderErrol P. Prens
- Topics
- Antibiotic Resistance in Bacteria (8 papers)Cystic Fibrosis Research Advances (7 papers)Antibiotics Pharmacokinetics and Efficacy (7 papers)
- Partner nations
- NetherlandsGermany
In The Last Decade
A. M. Horrevorts
34 papers receiving 817 citations
Peers
Comparison fields: 5 of 89
- Epidemiology 272
- Molecular Medicine 252
- Infectious Diseases 227
- Pharmacology 170
- Parasitology 166
Countries citing papers authored by A. M. Horrevorts
This map shows the geographic impact of A. M. Horrevorts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Horrevorts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Horrevorts more than expected).
Fields of papers citing papers by A. M. Horrevorts
This network shows the impact of papers produced by A. M. Horrevorts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Horrevorts. The network helps show where A. M. Horrevorts may publish in the future.
Co-authorship network of co-authors of A. M. Horrevorts
This figure shows the co-authorship network connecting the top 25 collaborators of A. M. Horrevorts. A scholar is included among the top collaborators of A. M. Horrevorts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. M. Horrevorts. A. M. Horrevorts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Preventie van lijninfecties door huiddesinfectie. | 0 |
| 2 | 35 | |
| 3 | 49 | |
| 4 | 19 | |
| 5 | Q-Fever outbreak in the Netherlands | 1 |
| 6 | 3 | |
| 7 | 4 | |
| 8 | 26 | |
| 9 | 16 | |
| 10 | 37 | |
| 11 | 34 | |
| 12 | 26 | |
| 13 | 2 | |
| 14 | [Postanginal sepsis caused by Fusobacterium necrophorum: Lemierre syndrome]. | 1 |
| 15 | 18 | |
| 16 | 12 | |
| 17 | 23 | |
| 18 | 16 | |
| 19 | 24 | |
| 20 | 3 |
About A. M. Horrevorts
A. M. Horrevorts is a scholar working on Molecular Medicine, Microbiology and Parasitology, having authored 35 papers that have together received 847 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (8 papers), Cystic Fibrosis Research Advances (7 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). The work is most often cited by research in Molecular Medicine (252 citations), Parasitology (166 citations) and Applied Microbiology and Biotechnology (42 citations). A. M. Horrevorts has collaborated with scholars based in Netherlands and Germany. Frequent co-authors include Marc Michel, Johan W. Mouton, Jacques F. Meis, Lenie Dijkshoorn, Ingela Tjernberg, K. F. Kerrebijn, Paul Mulder, Errol P. Prens, L.A.A. Kollée and Klasien A. Bergman. Their work appears in journals such as Clinical Infectious Diseases, CHEST Journal and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.